Información del producto
AZD1390 is a positron-emitting drug that can be used to study the molecular mechanisms of cancer. It binds to receptors on the surface of cells, activating cell signaling pathways, and is currently being studied for use in the treatment of squamous carcinoma. AZD1390 is able to penetrate solid tumours and it has been found to be effective against some types of cancer. The clinical studies showed that AZD1390 was safe and well-tolerated in patients with advanced cancers and that it had an acceptable side effect profile. This drug also has pharmacokinetic properties which make it suitable as a therapeutic agent.
Propiedades químicas
Consulta técnica sobre: 3D-PID28803 AZD1390
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
